NDC 72162-2424-01 - Metformin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2424
- Requested NDC
- 72162-2424-01
- Package NDCs from labels
- 72162-2424-0, 72162-2424-1, 72162-2424-2, 72162-2424-4, 72162-2424-5, 72162-2424-7, 72162-2424-9, 72162-2424-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2424-0 | Metformin | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | 101 | |
| 72162-2424-1 | Metformin | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 101 | |
| 72162-2424-2 | Metformin | 50 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 50 | 101 | |
| 72162-2424-4 | Metformin | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | 101 | |
| 72162-2424-5 | Metformin | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 101 | |
| 72162-2424-7 | Metformin | 360 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 360 | 101 | |
| 72162-2424-9 | Metformin | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2424 | METFORMIN (METFORMIN ER 500 MG) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 100 | Current NDC, 7 package rows | 20241114_c047cf64-467a-40f3-be46-a1926b3b8d56.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2424-0 | EA - Each | 72162-2424 | 91694f90-e166-48bf-80d0-593eab2ceb6d | 1 | 2024-12-10 |
| 72162-2424-1 | EA - Each | 72162-2424 | 2bdfc414-6ffb-436e-9d46-a426b4fa27f6 | 1 | 2024-12-10 |
| 72162-2424-2 | EA - Each | 72162-2424 | 38d3f3d2-30bb-481c-802a-7f04f1ae9494 | 1 | 2024-12-10 |
| 72162-2424-4 | EA - Each | 72162-2424 | 03c13ee4-9c27-4063-b7f0-9c4b648c6e27 | 1 | 2024-12-10 |
| 72162-2424-5 | EA - Each | 72162-2424 | 13b33fbd-50d4-4f73-81c2-4527532e9b82 | 1 | 2024-12-10 |
| 72162-2424-7 | EA - Each | 72162-2424 | 89627c8e-cbeb-45f6-bc2b-6b33eb1c6f91 | 1 | 2024-12-10 |
| 72162-2424-9 | EA - Each | 72162-2424 | 646cbc71-a8bc-4e1a-b569-5e4dfe39af0b | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | QPharma,Inc. | 5866ca12-a28f-cbe7-e063-6294a90acc69 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Jentadueto | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | f6dd9b86-0d18-95d4-2bc7-05591bfdd597 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Jentadueto XR | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 3d02a4d4-d312-80b4-05c4-691b8f0aa7aa | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 4dcef36f-000e-43f5-8d67-0e2a079ab2c6 | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin HCl | METFORMIN HCL | Unit Dose Solutions, Inc. | 5538e9df-0983-9281-e063-6394a90a9249 | 2026-08-18 | Warnings, Adverse reactions | 786Z46389E |
| KAZANO | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | Takeda Pharmaceuticals America, Inc. | 83cb7914-a683-47bb-a713-f2bc6a596bd2 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Sitagliptin and Metformin Hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Golden State Medical Supply, Inc. | 58f0e875-5d9b-be0b-e063-6394a90a5345 | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Quallent Pharmaceuticals Health LLC | 25be863d-490c-47f6-9ad3-c828dc43fbf0 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Sitagliptin and metformin hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 4d812277-21a8-4de3-b728-e3fdd01305b5 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Sitagliptin and metformin hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Zydus Lifesciences Limited | e07abcb1-1f0c-4cad-8405-8eedba4b8ff8 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| ZITUVIMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Zydus Lifesciences Limited | 0098dec4-f0e5-45d5-8aa4-5d0faf9ab142 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| SEGLUROMET | ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | a6aeb99a-ce49-4125-90ce-642df3f1ebad | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| JANUMET XR | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | 64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Redpharm Drug | 58bec665-b648-6baf-e063-6394a90a1cbb | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 860975 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | e22a8545-86a6-439e-a758-29c4d6ed8bfe | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| JANUMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | d19c7ed0-ad5c-426e-b2df-722508f97d67 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Synjardy XR | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 8006ba29-ee3a-f852-a9bb-c8ec9b41cf66 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| XIGDUO XR | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | AstraZeneca Pharmaceuticals LP | ac8a0f7b-9f69-4495-abbc-3a47cd75a859 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | c1bfc7b5-c7e0-4353-b772-05d463c12886 | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | 860975 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 1e8136e0-cc98-41e4-ad4b-a8fc27fb4daa | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.